A Study of Ustekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque Psoriasis
Clinical trial NCT01550744 · COMPLETED
Trial details
- NCT number
- NCT01550744
- Sponsor
- Janssen Biotech, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2015-05-01
- Enrollment
- 478
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.